Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: A case control study

Italian Journal of Pediatrics

Amal Gharib¹  Mohammed Osman²  Mohammed Sanad² 

[1]Department of Biochemistry, Faculty of Medicine, Zagazig University, Egypt

[2]Department of Pediatrics, Faculty of Medicine, Zagazig University, Egypt

关键词: Children;    Iron deficiency;    Hepcidin;    Obesity;   

Others  :  829312
DOI  :  10.1186/1824-7288-37-34

 received in 2011-03-18, accepted in 2011-07-19,  发布年份 2011

【 摘 要 】

Background

Recently, hepcidin expression in adipose tissue has been described and shown to be increased in patients with severe obesity. We tried to assess the effect of obesity on hepcidin serum levels and treatment outcome of iron deficiency anemia in children.

Methods

This was a case control study included 70 children with iron deficiency anemia "IDA" (35 obese and 35 non-obese) and 30 healthy non-obese children with comparable age and sex(control group). Parameters of iron status (Serum iron, ferritin, transferrin, total iron binding capacity and transferrin saturation) and serum hepcidin levels were assessed initially and after 3 months of oral iron therapy for IDA.

Results

Compared to the control group, serum hepcidin was significantly lower in non-obese children with IDA(p < 0.01) and significantly higher in obese children with IDA (p < 0.01). Hepcidin increased significantly in non-obese children with IDA after 3 months of iron therapy (P < 0.01). On the other hand, obese children showed non-significant change in hepcidin level after iron therapy (p > 0.05). Although hepcidin showed significant positive correlations with Hb, serum iron and transferrin saturation in non-obese children with IDA, it showed significant negative correlations with Hb, serum iron and transferrin saturation in obese children with IDA (P < 0.05).

Conclusions

Obesity increased hepcidin levels and was associated with diminished response to oral iron therapy in childhood iron deficiency anemia.

【 授权许可】

   
2011 Sanad et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Wenzel BJ, Stults HB, Mayer J: Hypoferraemia in obese adolescents. Lancet 1962, 2:327-28.
• [2]Seltzer CC, Mayer J: Serum iron and iron-binding capacity in adolescents: Comparison of obese and non-obese subjects. Am J Clin Nutr 1963, 13:354-61.
• [3]Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M: Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004, 114:104-8.
• [4]Whitfield JB, Treloar S, Zhu G, Powell LW, Martin NG: Relative importance of female-specific and non female-specific effects on variation in iron stores between women. Br J Haematol 2003, 120:860-66.
• [5]Lecube A, Carrera A, Losada E, Hernandez C, Simo R, Mesa J: Iron deficiency in obese postmenopausal women. Obesity (Silver Spring) 2006, 14:1724-30.
• [6]Failla ML, Kennedy ML, Chen ML: Iron metabolism in genetically obese (ob/ob) mice. J Nutr 1988, 118:46-51.
• [7]Menzie CM, Yanoff LB, Denkinger BI, Mchugh T, Sebring NG, Calis KA, Yanovski JA: Obesity related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc 2008, 108:145-48.
• [8]Haluzik M, Parizkova J, Haluzik MM: Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 2004, 3:123-29.
• [9]Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Srai SK, Tran A, Le Marchand-Brustel Y: Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006, 131:788-96.
• [10]Kemna E, Tjalsma H, Laarakkers C, Nemeth E, Willems H, Swinkels D: Novel urine hepcidin assay by mass spectrometry. Blood 2005, 106(9):3268-70.
• [11]Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loréal O: A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001, 276:7811-19.
• [12]Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S: Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002, 99:4596-601.
• [13]Dandona P, Aljada A, Bandyopadhyay A: Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004, 25:4-7.
• [14]Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, Lin HY: Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006, 38:531-39.
• [15]Goswami T, Andrews NC: Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 2006, 281:28494-98.
• [16]Weizer-Stern O, Adamsky K, Amariglio N, Levin C, Koren A, Breuer W, Rachmilewitz E, Breda L, Rivella , Cabantchik ZI, Rechavi G: Downregulation of hepcidin and haemojuvelin expression in the hepatocytes cell-line HepG2 induced by thalassaemic sera. Br J Haematol 2006, 135:129-38.
• [17]Verga Falzacappa MV, Spasic MV, Kessler R, Stolte J, Hentze MW, Muckenthaler MU: STAT-3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 2007, 109:353-58.
• [18]Cherian S, Forbes DA, Cook AG, Sanfilippo FM, Kemna EH, Swinkels DW, Burgner DP: An Insight into the Relationships between Hepcidin, Anemia, Infections and Inflammatory Cytokines in Pediatric Refugees: A Cross-Sectional Study. PLoS ONE 2008, 3(12):e4030.
• [19]Metzgeroth G, Adelberger V, Dorn-Beineke A, Kuhn C, Schatz M, Maywald O, Bertsch T, Wisser H, Hehlmann R, Hastka J: Soluble transferrin receptor and zinc protoporphyrin--competitors or efficient partners? Eur J Haematol 2005, 75:309-17.
• [20]Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M: Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004, 114:104-8.
• [21]Gillum RF: Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men: the Third National Health and Nutrition Examination Survey. Int J Obes 2001, 25:639-45.
• [22]Zimmermann MB, Zeder C, Muthayya S, Winichagoon P, Chaouki N, Aeberli I, Hurrell RF: Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Int J Obes 2008, 32:1098-104.
• [23]del Giudice EM, Santoro N, Amato A, Brienza C, Calabrò P, Wiegerinck ET, Cirillo G, Tartaglione N, Grandone A, Swinkels DW, Perrone L: Hepcidin in Obese Children as a Potential Mediator of the Association between Obesity and Iron Deficiency. J Clin Endocrinol Metab 2009, 94(12):5102-7.
• [24]Yanoff LB, Menzie CM, Denkinger B, Sebring NG, McHugh T, Remaley AT, Yanovski JA: Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond) 2007, 31(9):1412-19.
• [25]Greenberg AS, Obin MS: Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006, 83:461S-465S.
• [26]Fitzsimons EJ, Brock JH: The anemia of chronic disease. Bmj 2001, 322:811-12.
• [27]Rogers JT: Ferritin translation by interleukin-1 and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 1996, 87:2525-37.
• [28]Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M: Immunoassay for human serum hepcidin. Blood 2008, 112(10):4292-97.
• [29]Nemeth E: Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemia. Adv Hematol 2010, 750643. 2010
• [30]Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T: Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003, 101:2461-63.
• [31]Laftah AH, Ramesh B, Simpson RJ, Solanky N, Bahram S, Schumann K, Debnam ES, Srai SK: Effect of hepcidin on intestinal iron absorption in mice. Blood 2004, 103:3940-44.
• [32]Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M: Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 over expression and down-regulated by hepcidin. Proc Natl Acad Sci USA 2005, 102:1324-28.
• [33]Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T: IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004, 113:1271-76.
• [34]Lin L, Goldbberg YP, Ganz T: Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 2005, 106:2884-89.
• [35]Vokurka M, Lacinova Z, Kremen J, Kopecky P, Blaha J, Pelinkova K, Haluzík M, Necas E: Hepcidin Expression in Adipose Tissue Increases during Cardiac Surgery. Physiol Res 2010, 59:393-400.
• [36]Anty R, Dahman M, Iannelli A, Gual P, Staccini-Myx A, Amor IB, Luciani N, Saint-Paul MC, Huet PM, Sadoul JL, Srai SK, Unwin R, Gugenheim J, Le Marchand-Brustel Y, Tran A, Bekri S: Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation. Obes Surg 2008, 18:709-14.